BackPeak Bio- Warrants (05/01/2026) Overview
Peak Bio Inc - Warrants (05/01/2026)

Peak Bio- Warrants (05/01/2026) Return on Equity

Peak Bio- Warrants (05/01/2026) (PKBOW) has a ROE of 30560.43%, above the sector sector average of -6.13%.

Get informed when a big investor buys or sells

+ Follow

ROE

30560.43%

Return on Equity

30560.43%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Peak Bio- Warrants (05/01/2026) (PKBOW) FAQ

Peak Bio- Warrants (05/01/2026)'s return on equity stands at 30560.43%. That is above the sector sector average of -6.13%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Peak Bio- Warrants (05/01/2026) sits higher the its sector benchmark (-6.13%) with a ROE of 30560.43%. That is roughly 498778.7% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 30560.43% for Peak Bio- Warrants (05/01/2026) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Peak Bio- Warrants (05/01/2026)'s ROE evolved across reporting periods, while the comparison chart places PKBOW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.